Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Karin Garming-Legert"'
Autor:
Amila Larsson, Tobias Regnstrand, Pia Skott, Outi Mäkitie, Sigridur Björnsdottir, Karin Garming-Legert
Publikováno v:
Frontiers in Oral Health, Vol 4 (2023)
ObjectiveThe present study compared the dental health of patients with X-linked hypophosphatemia (XLH) with healthy age- and gender-matched controls to increase our knowledge of the impact of XLH on oral health.Materials and methodsTwenty-two adult p
Externí odkaz:
https://doaj.org/article/275307fecc5f4b3eb09e4174433a5820
Autor:
Johan Törlén, Olle Ringdén, Karin Garming-Legert, Per Ljungman, Jacek Winiarski, Kari Remes, Maija Itälä-Remes, Mats Remberger, Jonas Mattsson
Publikováno v:
Haematologica, Vol 101, Iss 11 (2016)
Improvement of graft-versus-host disease prophylaxis remains an important goal in allogeneic hematopoietic stem cell transplantation. Based on reports of possibly preferential properties of sirolimus, we compared the standard regimen of cyclosporine
Externí odkaz:
https://doaj.org/article/43054f3c64974fec98ba1876667b39cd
Treatment of chronic GvHD with mesenchymal stromal cells induces durable responses: A phase II study
Autor:
Erik Boberg, Lena vonBahr, Gabriel Afram, Carina Lindström, Per Ljungman, Nina Heldring, Peter Petzelbauer, Karin Garming Legert, Nadir Kadri, Katarina Le Blanc
Publikováno v:
Stem Cells Translational Medicine, Vol 9, Iss 10, Pp 1190-1202 (2020)
Abstract Steroid‐refractory chronic graft‐vs‐host disease (cGvHD) contributes to morbidity after allogeneic hematopoietic stem cell transplantation. Here, we report on 11 patients with severe, refractory cGvHD treated with repeated infusions of
Externí odkaz:
https://doaj.org/article/16d0c6414fc74e21b153c67ffa2c49aa
Autor:
Kristina Skallsjö, Inger von Bültzingslöwen, Bengt Hasséus, Jan-Erik Johansson, Jenny Öhman, Judith E. Raber-Durlacher, Marie-Charlotte D. N. J. M. Huysmans, Alexa M. G. A. Laheij, Stephanie J. M. van Leeuwen, Allan J. Hovan, Karin Garming Legert, Hieu M. Nguyen, Philip J. Turk, Frederik R. Rozema, Nicole M. A. Blijlevens, Michael T. Brennan
Publikováno v:
Skallsjö, K, von Bültzingslöwen, I, Hasséus, B, Johansson, J E, Öhman, J, Raber-Durlacher, J E, Huysmans, M C D N J M, Laheij, A M G A, van Leeuwen, S J M, Hovan, A J, Legert, K G, Nguyen, H M, Turk, P J, Rozema, F R, Blijlevens, N M A & Brennan, M T 2023, ' Oral health in patients scheduled for hematopoietic stem cell transplantation in the Orastem study ', PLoS ONE, vol. 18, no. 5, e0285615, pp. 1-18 . https://doi.org/10.1371/journal.pone.0285615
PLoS One, 18
PLoS One, 18, 5
PLoS ONE, 18(5 May):e0285615. Public Library of Science
PLoS ONE, 18(5):e0285615, 1-18. Public Library of Science
Skallsjö, K, von Bültzingslöwen, I, Hasséus, B, Johansson, J-E, Öhman, J, Raber-Durlacher, J E, Huysmans, M-C D N J M, Laheij, A M G A, van Leeuwen, S J M, Hovan, A J, Legert, K G, Nguyen, H M, Turk, P J, Rozema, F R, Blijlevens, N M A & Brennan, M T 2023, ' Oral health in patients scheduled for hematopoietic stem cell transplantation in the Orastem study ', PLoS ONE, vol. 18, no. 5 May, e0285615 . https://doi.org/10.1371/journal.pone.0285615
PLoS One, 18
PLoS One, 18, 5
PLoS ONE, 18(5 May):e0285615. Public Library of Science
PLoS ONE, 18(5):e0285615, 1-18. Public Library of Science
Skallsjö, K, von Bültzingslöwen, I, Hasséus, B, Johansson, J-E, Öhman, J, Raber-Durlacher, J E, Huysmans, M-C D N J M, Laheij, A M G A, van Leeuwen, S J M, Hovan, A J, Legert, K G, Nguyen, H M, Turk, P J, Rozema, F R, Blijlevens, N M A & Brennan, M T 2023, ' Oral health in patients scheduled for hematopoietic stem cell transplantation in the Orastem study ', PLoS ONE, vol. 18, no. 5 May, e0285615 . https://doi.org/10.1371/journal.pone.0285615
Contains fulltext : 292890.pdf (Publisher’s version ) (Open Access) Despite advances in transplant medicine, prevalence of complications after hematopoietic stem cell transplantation (HSCT) remains high. The impact of pre-HSCT oral health factors o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a8e73f03e5ee83becd91329218168f5
https://research.vu.nl/en/publications/7705dadd-7463-44f6-a957-01739e1e532d
https://research.vu.nl/en/publications/7705dadd-7463-44f6-a957-01739e1e532d
Autor:
Victor Tollemar, Jennifer Ström, Nikolce Tudzarovski, Henrike Häbel, Karin Garming Legert, Robert Heymann, Gunnar Warfvinge, Katarina Le Blanc, Rachael Victoria Sugars
Publikováno v:
Oral diseasesREFERENCES.
Chronic graft-versus-host disease (cGVHD) is the main cause of late non-relapse mortality following hematopoietic cell transplantation. Oral mucosal (om-) cGVHD is common, but diagnosis and assessment rely on clinical interpretation and patient-repor
Publikováno v:
Oral Diseases
Objectives To determine whether treatment with tacrolimus plus sirolimus (Tac/Sir) as a prophylaxis for graft‐versus‐host disease worsens severe oral mucositis and delays healing compared to cyclosporine plus methotrexate (CsA/Mtx) following haem
Treatment of chronic GvHD with mesenchymal stromal cells induces durable responses: A phase II study
Autor:
Carina Lindström, Lena von Bahr, Nina Heldring, Katarina Le Blanc, Erik Boberg, Karin Garming Legert, Per Ljungman, Nadir Kadri, Peter Petzelbauer, Gabriel Afram
Publikováno v:
Stem Cells Translational Medicine, Vol 9, Iss 10, Pp 1190-1202 (2020)
Stem Cells Translational Medicine
Stem Cells Translational Medicine
Steroid‐refractory chronic graft‐vs‐host disease (cGvHD) contributes to morbidity after allogeneic hematopoietic stem cell transplantation. Here, we report on 11 patients with severe, refractory cGvHD treated with repeated infusions of allogene
Autor:
Gustaf Ljungman, Jacek Toporski, Anncarin Svanberg, Louise von Essen, Johan Arvidson, Jacek Winiarski, Karin Mellgren, Tove Kamsvåg, Karin Garming Legert
Publikováno v:
Supportive Care in Cancer
Purpose To evaluate the feasibility of oral cryotherapy (OC) in children and to investigate if OC reduces the incidence of severe oral mucositis (OM), oral pain, and opioid use in children undergoing hematopoietic stem cell transplantation (HSCT). Me
Autor:
Björn Tavelin, Fredrik Schjesvold, Gunnar Larfors, Mats Jontell, Aram Mahdi, Douglas E. Peterson, Roger Henriksson, Java Walladbegi, Karin Garming Legert, Martin Jädersten, Anncarin Svanberg
Cryoprevention (CP) using ice (IC) is an effective strategy to prevent chemotherapy-induced oral mucositis (OM). However, the use of IC may cause adverse reactions and requires water of safe quality to minimize risk of serious infections. This random
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da334638b515da7ae2ae968ac0ce7eed
http://hdl.handle.net/10852/92578
http://hdl.handle.net/10852/92578
Autor:
Java, Walladbegi, Roger, Henriksson, Björn, Tavelin, Anncarin, Svanberg, Gunnar, Larfors, Martin, Jädersten, Fredrik, Schjesvold, Aram, Mahdi, Karin, Garming Legert, Douglas E, Peterson, Mats, Jontell
Publikováno v:
Bone marrow transplantation. 57(2)
Cryoprevention (CP) using ice (IC) is an effective strategy to prevent chemotherapy-induced oral mucositis (OM). However, the use of IC may cause adverse reactions and requires water of safe quality to minimize risk of serious infections. This random